Effect of daily consumption of extra virgin olive oil on the lipid profile and microbiota of HIV-infected patients over 50 years of age
Metadata
Show full item recordAuthor
Olalla, Julián; Chueca-Porcuna, Natalia; Salazar, Adolfo de; Plaza Díaz, Julio; García, FedericoEditorial
Wolters Kluwer Health, Inc.
Materia
Aging Cholesterol Extra-virgin olive oil Microbiota
Date
2019-09-19Referencia bibliográfica
Olalla, J., de Lomas, J. M. G., Chueca, N., Pérez-Stachowski, X., De Salazar, A., Del Arco, A., ... & Fernández-Sánchez, F. (2019). Effect of daily consumption of extra virgin olive oil on the lipid profile and microbiota of HIV-infected patients over 50 years of age. Medicine, 98(42).
Sponsorship
This work was financed in part by Grants from Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER (RD16/0025/0040; http:// www.isciii.es/isciii/es/contenidos/fd-investigacion/fd-ejecucion/fd-centrosparticipados/ centros-participados-redesretics.shtml) and Fondo de Investigación Sanitaria (PI 18/00819).Abstract
Extra virgin olive oil (EVOO) has shown beneficial effects on the lipid profile and inflammatory parameters in
general population. Our goal is to analyze these changes together with those of intestinal microbiota in human immunodeficiency
virus (HIV)-infected patients over 50 years of age. Total cholesterol decreased significantly (5 mg/dL), and a nonsignificant decrease in low-density lipoprotein cholesterol
(12 mg/dL), triglycerides (21 mg/dL), and CRP (1.25 mg/dL) was observed. There was a significant increase in alpha diversity
after the intervention in men and a decrease in proinflammatory genera such as Dethiosulfovibrionaceae was observed. Differences
were also observed in the microbiota of men and women and according to the type of antiretroviral treatment. Sustained consumption of 50g of EVOO in elderly HIV-infected patients might be associated with an improvement in
lipid profile and alfa diversity of intestinal microbiota.